In this fifth episode of the Deep Dive into MDS 3.0 Quality Measures podcast series, AANAC curriculum development specialist, Jane Belt, MS, RN, QCP, RAC-MT, RAC-MTA, discusses two long-stay antianxiety/hypnotic medication MDS 3.0 Quality Measures—the Prevalence of Antianxiety/Hypnotic Use and the Percent of Residents Who Used an Antianxiety or Hypnotic Medication.

In this podcast, AANAC curriculum development specialist, Jessie McGill, RN, RAC-MT, RAC-MTA, will discuss two antipsychotic medication-related measures, the short-stay measure—Percent of Residents Who Newly Received an Antipsychotic Medication, and the long-stay measure—Percent of Residents Who Received an Antipsychotic Medication. McGill will discuss the rationale, what is the numerator, denominator, the exclusions, covariates as well as a possible action plan for greater success.

Deep Dive into MDS 3.0 Quality Measures Series: Episode 003 - Help for Daily Activities Increased and Ability to Move Worsened

Deep Dive into MDS 3.0 Quality Measures: Episode 002 - Pressure Ulcers

Deep Dive into MDS 3.0 Quality Measures Podcast Series: Episode 001 - Falls with Major Injury and Prevalence of Falls

MDS Item Sets Breakdown

The Waivers NACs Need to Know

Spotlight on You: Episode 1

How to Catch Up on MDS Assessments

Isolation and Cohorting During the COVID-19 Pandemic